BUZZ-Karyopharm stock plummets after bankruptcy filing, merger plan with Ayrmid

November 2 - ** Shares of Karyopharm Therapeutics (KPTI.O) plunged 75.8% to $0.16 in pre-market trading

** Karyopharm filed for Chapter 11 bankruptcy protection (link)

** Karyopharm reached a restructuring agreement and plans to merge with Ayrmid

** Karyopharm stated that Ayrmid is serving as the lead bidder in a court-supervised sale process, and other parties can also submit competing bids

** Karyopharm has secured up to $55 million in financing commitments and said its business is expected to continue operating during this process

** As of the previous trading day's close, the stock had fallen 91% year to date, with a market capitalization of $15 million — LSEG

(To facilitate non-English speakers, Reuters automatically translates its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation, which is provided solely for the convenience of readers. Reuters assumes no responsibility for any damage or loss arising from the use of the automated translation function.)